{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T00:09:54Z","timestamp":1788480594072,"version":"build-2803163510"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"23-24","license":[{"start":{"date-parts":[[2023,1,12]],"date-time":"2023-01-12T00:00:00Z","timestamp":1673481600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,1,12]],"date-time":"2023-01-12T00:00:00Z","timestamp":1673481600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100011852","name":"Paracelsus Medical University","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100011852","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Wien Klin Wochenschr"],"published-print":{"date-parts":[[2023,12]]},"abstract":"<jats:title>Summary<\/jats:title><jats:sec>\n                <jats:title>Introduction<\/jats:title>\n                <jats:p>Selection in patients with functional mitral regurgitation (MR) to identify responders to interventions is challenging. In these patients, frailty might be used as a\u00a0multidimensional parameter to summarize the resilience to stressors. Our objective was to evaluate frailty as a\u00a0predictor of outcome in patients with moderate to severe secondary MR.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>We conducted a\u00a0single-center retrospective observational cohort study and included 239 patients with moderate to severe secondary MR aged 65\u00a0years or older between 2014 and 2020. Echocardiography was performed at baseline; frailty was evaluated using the clinical frailty scale (CFS). The combined primary endpoint was hospitalization for heart failure and all-cause mortality.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>A\u00a0total of 53% (127) of all patients were classified as CFS 4 (living with mild frailty) or higher. Frail patients had a\u00a0higher risk for the combined endpoint (hazard ratio, HR 3.70, 95% confidence interval, CI 2.12\u20136.47; <jats:italic>p<\/jats:italic>\u202f&lt;\u20090.001), 1\u2011year mortality (HR 5.94, 95% CI 1.76\u201320.08; <jats:italic>p<\/jats:italic>\u202f&lt;\u20090.001) even after adjustment for EuroSCORE2. The CFS was predictive for the combined endpoint (AUC 0.69, 95% CI 0.62\u20130.75) and outperformed EuroSCORE2 (AUC 0.54, 95% CI 0.46\u20130.62; <jats:italic>p<\/jats:italic>\u202f=\u20090.01). In sensitivity analyses, we found that frailty was associated with adverse outcomes at least in trend in all subgroups.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusion<\/jats:title>\n                <jats:p>For older, medically treated patients with moderate to severe secondary mitral regurgitation, frailty is an independent predictor for the occurrence of death and heart failure-related readmission within 1 year and outperformed the EuroSCORE2. Frailty should be assessed routinely in patients with heart failure to guide clinical decision making for mitral valve interventions or conservative treatment.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1007\/s00508-022-02138-4","type":"journal-article","created":{"date-parts":[[2023,1,12]],"date-time":"2023-01-12T16:03:02Z","timestamp":1673539382000},"page":"696-702","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Frailty as a\u00a0predictor of mortality and readmission rate in secondary mitral regurgitation"],"prefix":"10.1007","volume":"135","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5125-3468","authenticated-orcid":false,"given":"Robert","family":"Uzel","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard","family":"Rezar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raphael Romano","family":"Bruno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah","family":"Wernly","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian","family":"Jung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Georg","family":"Delle Karth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian","family":"Datz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Friedrich","family":"Hoppichler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bernhard","family":"Wernly","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,1,12]]},"reference":[{"key":"2138_CR1","doi-asserted-by":"publisher","first-page":"3515","DOI":"10.1093\/eurheartj\/ehw229","volume":"37","author":"JL d\u2019Arcy","year":"2016","unstructured":"d\u2019Arcy\u00a0JL, Coffey\u00a0S, Loudon\u00a0MA, Kennedy\u00a0A, Pearson-Stuttard\u00a0J, Birks\u00a0J, et al. Large-scale community echocardiographic screening reveals a\u00a0major burden of undiagnosed valvular heart disease in older people: the OxVALVE population cohort study. Eur Heart\u00a0J. 2016;37:3515\u201322.","journal-title":"Eur Heart J"},{"key":"2138_CR2","doi-asserted-by":"publisher","first-page":"1005","DOI":"10.1016\/S0140-6736(06)69208-8","volume":"368","author":"VT Nkomo","year":"2006","unstructured":"Nkomo\u00a0VT, Gardin\u00a0JM, Skelton\u00a0TN, Gottdiener\u00a0JS, Scott\u00a0CG, Enriquez-Sarano\u00a0M. Burden of valvular heart diseases: a\u00a0population-based study. Lancet. 2006;368:1005\u201311.","journal-title":"Lancet"},{"key":"2138_CR3","unstructured":"Redaktion Deutsches \u00c4rzteblatt. Herzinsuffizienz: H\u00e4ufigster Grund f\u00fcr Kranken-haus-auf-enthalte \u2013 Medizinische und \u00f6konomische Aspekte: Grunderkrankungen ber\u00fccksichtigen. 2009. https:\/\/www.aerzteblatt.de\/archiv\/65770\/Herzinsuffizienz-Haeufigster-Grund-fuer-Kranken-haus-auf-enthalte-Medizinische-und-oekonomische-Aspekte-Grunderkrankungen-beruecksichtigen. Accessed 6 June 2020."},{"key":"2138_CR4","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1093\/eurheartj\/ehab395","volume":"43","author":"A Vahanian","year":"2022","unstructured":"Vahanian\u00a0A, Beyersdorf\u00a0F, Praz\u00a0F, Milojevic\u00a0M, Baldus\u00a0S, Bauersachs\u00a0J, et al. 2021 ESC\/EACTS guidelines for the management of valvular heart disease: developed by the task force for the management of valvular heart disease of the European society of cardiology (ESC) and the European association for cardio-thoracic surgery (EACTS). Eur Heart\u00a0J. 2022;43:561\u2013632.","journal-title":"Eur Heart J"},{"key":"2138_CR5","doi-asserted-by":"publisher","first-page":"2739","DOI":"10.1093\/eurheartj\/ehx391","volume":"38","author":"H Baumgartner","year":"2017","unstructured":"Baumgartner\u00a0H, Falk\u00a0V, Bax\u00a0JJ, De Bonis\u00a0M, Hamm\u00a0C, Holm\u00a0PJ, et\u00a0al. 2017 ESC\/EACTS guidelines for the management of valvular heart disease. Eur Heart\u00a0J. 2017;38:2739\u201391.","journal-title":"Eur Heart J"},{"key":"2138_CR6","doi-asserted-by":"publisher","first-page":"3411","DOI":"10.1161\/CIRCULATIONAHA.104.508093","volume":"111","author":"SD Solomon","year":"2005","unstructured":"Solomon\u00a0SD, Skali\u00a0H, Anavekar\u00a0NS, Bourgoun\u00a0M, Barvik\u00a0S, Ghali\u00a0JK, et\u00a0al. Changes in ventricular size and function in patients treated with valsartan, captopril, or both after myocardial infarction. Circulation. 2005;111:3411\u20139.","journal-title":"Circulation"},{"key":"2138_CR7","doi-asserted-by":"publisher","first-page":"1354","DOI":"10.1161\/CIRCULATIONAHA.118.037077","volume":"139","author":"D-H Kang","year":"2019","unstructured":"Kang\u00a0D\u2011H, Park\u00a0S\u2011J, Shin\u00a0S\u2011H, Hong\u00a0G\u2011R, Lee\u00a0S, Kim\u00a0M\u2011S, et al. Angiotensin receptor neprilysin inhibitor for functional mitral regurgitation. Circulation. 2019;139:1354\u201365.","journal-title":"Circulation"},{"key":"2138_CR8","doi-asserted-by":"publisher","first-page":"596","DOI":"10.1016\/S0002-8703(00)90036-X","volume":"139","author":"S Capomolla","year":"2000","unstructured":"Capomolla\u00a0S, Febo\u00a0O, Gnemmi\u00a0M, Riccardi\u00a0G, Opasich\u00a0C, Caporotondi\u00a0A, et al. Beta-blockade therapy in chronic heart failure: diastolic function and mitral regurgitation improvement by carvedilol. Am Heart\u00a0J. 2000;139:596\u2013608.","journal-title":"Am Heart J"},{"key":"2138_CR9","doi-asserted-by":"publisher","first-page":"912","DOI":"10.1161\/CIRCULATIONAHA.110.009803","volume":"124","author":"RJ van Bommel","year":"2011","unstructured":"van Bommel\u00a0RJ, Marsan\u00a0NA, Delgado\u00a0V, Borleffs\u00a0CJW, van Rijnsoever\u00a0EPM, Schalij\u00a0MJ, et al. Cardiac resynchronization therapy as a\u00a0therapeutic option in patients with moderate-severe functional mitral regurgitation and high operative risk. Circulation. 2011;124:912\u20139.","journal-title":"Circulation"},{"key":"2138_CR10","doi-asserted-by":"publisher","first-page":"1787","DOI":"10.1093\/eurheartj\/ehs104","volume":"33","author":"JJV McMurray","year":"2012","unstructured":"McMurray\u00a0JJV, Adamopoulos\u00a0S, Anker\u00a0SD, Auricchio\u00a0A, B\u00f6hm\u00a0M, Dickstein\u00a0K, et\u00a0al. ESC guidelines for the diagnosis and treatment of acute and chronic heart failure 2012: the task force for the diagnosis and treatment of acute and chronic heart failure 2012 of the European society of cardiology. Developed in collaboration with the heart failure association (HFA) of the ESC. Eur Heart\u00a0J. 2012of;33:1787\u2013847.","journal-title":"Eur Heart J"},{"key":"2138_CR11","doi-asserted-by":"publisher","first-page":"1358","DOI":"10.1093\/eurheartj\/ehm001","volume":"28","author":"M Mirabel","year":"2007","unstructured":"Mirabel\u00a0M, Iung\u00a0B, Baron\u00a0G, Messika-Zeitoun\u00a0D, D\u00e9taint\u00a0D, Vanoverschelde\u00a0J\u2011L, et al. What are the characteristics of patients with severe, symptomatic, mitral regurgitation who are denied surgery? Eur Heart\u00a0J. 2007;28:1358\u201365.","journal-title":"Eur Heart J"},{"key":"2138_CR12","doi-asserted-by":"crossref","unstructured":"Iung B, Delgado V, Murray S, Hayes S, De Bonis M, Rosenhek R, et al. Real-life management of mitral regurgitations. Lesson from a\u00a0European survey. 2017. https:\/\/academic.oup.com\/eurheartj\/article\/38\/suppl_1\/ehx493.P5811\/4086972. Accessed 13 May 2020.","DOI":"10.1093\/eurheartj\/ehx493.P5811"},{"key":"2138_CR13","doi-asserted-by":"publisher","first-page":"1487","DOI":"10.1111\/j.1532-5415.2012.04054.x","volume":"60","author":"RM Collard","year":"2012","unstructured":"Collard\u00a0RM, Boter\u00a0H, Schoevers\u00a0RA, Oude Voshaar\u00a0RC. Prevalence of frailty in community-dwelling older persons: a\u00a0systematic review. J\u00a0Am Geriatr Soc. 2012;60:1487\u201392.","journal-title":"J Am Geriatr Soc"},{"key":"2138_CR14","doi-asserted-by":"publisher","first-page":"e0219083","DOI":"10.1371\/journal.pone.0219083","volume":"14","author":"SJG Richards","year":"2019","unstructured":"Richards\u00a0SJG, D\u2019Souza\u00a0J, Pascoe\u00a0R, Falloon\u00a0M, Frizelle\u00a0FA. Prevalence of frailty in a\u00a0tertiary hospital: a point prevalence observational study. PLoS ONE. 2019;14:e219083.","journal-title":"PLoS ONE"},{"key":"2138_CR15","first-page":"e008456","volume":"5","author":"J Soong","year":"2015","unstructured":"Soong\u00a0J, Poots\u00a0AJ, Scott\u00a0S, Donald\u00a0K, Woodcock\u00a0T, Lovett\u00a0D, et\u00a0al. Quantifying the prevalence of frailty in English hospitals. BMJ. 2015;5:e8456.","journal-title":"BMJ"},{"key":"2138_CR16","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1471-2318-14-1","volume":"14","author":"E Joosten","year":"2014","unstructured":"Joosten\u00a0E, Demuynck\u00a0M, Detroyer\u00a0E, Milisen\u00a0K. Prevalence of frailty and its ability to predict in hospital delirium, falls, and 6\u2011month mortality in hospitalized older patients. BMC Geriatr. 2014;14:1.","journal-title":"BMC Geriatr"},{"key":"2138_CR17","doi-asserted-by":"publisher","first-page":"afab278","DOI":"10.1093\/ageing\/afab278","volume":"51","author":"IW Soliman","year":"2022","unstructured":"Soliman\u00a0IW, Leaver\u00a0S, Flaatten\u00a0H, Fj\u00f8lner\u00a0J, Wernly\u00a0B, Bruno\u00a0RR, et al. Health-related quality of life in older patients surviving ICU treatment for COVID-19: results from an international observational study of patients older than 70\u00a0years. Age Ageing. 2022;51:afab278.","journal-title":"Age Ageing"},{"key":"2138_CR18","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1186\/s13054-021-03551-3","volume":"25","author":"C Jung","year":"2021","unstructured":"Jung\u00a0C, Flaatten\u00a0H, Fj\u00f8lner\u00a0J, Bruno\u00a0RR, Wernly\u00a0B, Artigas\u00a0A, et al. The impact of frailty on survival in elderly intensive care patients with COVID-19: the COVIP study. Crit Care. 2021;25:149.","journal-title":"Crit Care"},{"key":"2138_CR19","unstructured":"Dalhous. Univ.. Clinical frailty scale.. https:\/\/www.dal.ca\/sites\/gmr\/our-tools\/clinical-frailty-scale.html. Accessed 28 Mar 2022."},{"key":"2138_CR20","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1007\/s00134-019-05853-1","volume":"46","author":"B Guidet","year":"2020","unstructured":"Guidet\u00a0B, de Lange\u00a0DW, Boumendil\u00a0A, Leaver\u00a0S, Watson\u00a0X, Boulanger\u00a0C, et\u00a0al. The contribution of frailty, cognition, activity of daily life and comorbidities on outcome in acutely admitted patients over 80\u00a0years in European ICUs: the VIP2\u00a0study. Intensive Care Med. 2020;46:57\u201369.","journal-title":"Intensive Care Med"},{"key":"2138_CR21","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1093\/ejechocard\/jeq031","volume":"11","author":"P Lancellotti","year":"2010","unstructured":"Lancellotti\u00a0P, Moura\u00a0L, Pierard\u00a0LA, Agricola\u00a0E, Popescu\u00a0BA, Tribouilloy\u00a0C, et\u00a0al. European association of echocardiography recommendations for the assessment of valvular regurgitation. Part 2: mitral and tricuspid regurgitation (native valve disease). Eur J Echocardiogr. 2010;11:307\u201332.","journal-title":"Eur J Echocardiogr"},{"key":"2138_CR22","doi-asserted-by":"publisher","first-page":"210","DOI":"10.5770\/cgj.23.463","volume":"23","author":"K Rockwood","year":"2020","unstructured":"Rockwood\u00a0K, Theou\u00a0O. Using the clinical frailty scale in allocating scarce health care resources. Can Geriatr\u00a0J. 2020;23:210\u20135.","journal-title":"Can Geriatr J"},{"key":"2138_CR23","doi-asserted-by":"publisher","DOI":"10.1007\/s11606-021-07199-1","author":"FY Hu","year":"2022","unstructured":"Hu\u00a0FY, Streiter\u00a0S, O\u2019Mara\u00a0L, Sison\u00a0SM, Theou\u00a0O, Bernacki\u00a0R, et al. Frailty and survival after in-hospital cardiopulmonary resuscitation. J\u00a0Gen Intern Med. 2022; https:\/\/doi.org\/10.1007\/s11606-021-07199-1.","journal-title":"J Gen Intern Med"},{"key":"2138_CR24","doi-asserted-by":"publisher","first-page":"734","DOI":"10.1093\/ejcts\/ezs043","volume":"41","author":"SAM Nashef","year":"2012","unstructured":"Nashef\u00a0SAM, Roques\u00a0F, Sharples\u00a0LD, Nilsson\u00a0J, Smith\u00a0C, Goldstone\u00a0AR, et\u00a0al. EuroSCORE II. Eur J Cardiothorac Surg. 2012;41:734\u201345.","journal-title":"Eur J Cardiothorac Surg"},{"key":"2138_CR25","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1016\/j.amjcard.2015.10.044","volume":"117","author":"C Giannini","year":"2016","unstructured":"Giannini\u00a0C, Fiorelli\u00a0F, De Carlo\u00a0M, Guarracino\u00a0F, Faggioni\u00a0M, Giordano\u00a0P, et\u00a0al. Comparison of percutaneous mitral valve repair versus conservative treatment in severe functional mitral regurgitation. Am J Cardiol. 2016;117:271\u20137.","journal-title":"Am J Cardiol"},{"key":"2138_CR26","doi-asserted-by":"publisher","first-page":"1920","DOI":"10.1016\/j.jcin.2017.07.042","volume":"10","author":"C Metze","year":"2017","unstructured":"Metze\u00a0C, Matzik\u00a0A\u2011S, Scherner\u00a0M, K\u00f6rber\u00a0MI, Michels\u00a0G, Baldus\u00a0S, et al. Impact of frailty on outcomes in patients undergoing percutaneous mitral valve repair. JACC Cardiovasc Interv. 2017;10:1920\u20139.","journal-title":"JACC Cardiovasc Interv"},{"key":"2138_CR27","doi-asserted-by":"publisher","first-page":"2297","DOI":"10.1056\/NEJMoa1805374","volume":"379","author":"J-F Obadia","year":"2018","unstructured":"Obadia\u00a0J\u2011F, Messika-Zeitoun\u00a0D, Leurent\u00a0G, Iung\u00a0B, Bonnet\u00a0G, Piriou\u00a0N, et al. Percutaneous repair or medical treatment for secondary mitral regurgitation. N\u00a0Engl J Med. 2018;379:2297\u2013306.","journal-title":"N Engl J Med"},{"key":"2138_CR28","doi-asserted-by":"publisher","first-page":"2307","DOI":"10.1056\/NEJMoa1806640","volume":"379","author":"GW Stone","year":"2018","unstructured":"Stone\u00a0GW, Lindenfeld\u00a0J, Abraham\u00a0WT, Kar\u00a0S, Lim\u00a0DS, Mishell\u00a0JM, et al. Transcatheter mitral-valve repair in patients with heart failure. N\u00a0Engl J Med. 2018;379:2307\u201318.","journal-title":"N Engl J Med"},{"key":"2138_CR29","unstructured":"Simpson TF, Kumar K, Samhan A, Khan O, Khan K, Strehler K, et\u00a0al. Clinical predictors of mortality in patients with moderate to severe mitral regurgitation. 2021. https:\/\/www.sciencedirect.com\/science\/article\/pii\/S0002934321006392. Accessed 24 Oct 2021."},{"key":"2138_CR30","doi-asserted-by":"publisher","first-page":"960","DOI":"10.1016\/S0140-6736(18)30473-2","volume":"391","author":"V Dziadzko","year":"2018","unstructured":"Dziadzko\u00a0V, Clavel\u00a0M\u2011A, Dziadzko\u00a0M, Medina-Inojosa\u00a0JR, Michelena\u00a0H, Maalouf\u00a0J, et al. Outcome and undertreatment of mitral regurgitation: a\u00a0community cohort study. Lancet. 2018;391:960\u20139.","journal-title":"Lancet"},{"key":"2138_CR31","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1016\/j.jcrc.2020.07.024","volume":"60","author":"RR Bruno","year":"2020","unstructured":"Bruno\u00a0RR, Wernly\u00a0B, Beil\u00a0M, Muessig\u00a0JM, Rahmel\u00a0T, Graf\u00a0T, et\u00a0al. Therapy limitation in octogenarians in German intensive care units is associated with a\u00a0longer length of stay and increased 30\u00a0days mortality: a prospective multicenter study. J\u00a0Crit Care. 2020;60:58\u201363.","journal-title":"J Crit Care"},{"key":"2138_CR32","first-page":"123","volume":"3","author":"A Anand","year":"2017","unstructured":"Anand\u00a0A, Harley\u00a0C, Visvanathan\u00a0A, Shah\u00a0ASV, Cowell\u00a0J, MacLullich\u00a0A, et al. The relationship between preoperative frailty and outcomes following transcatheter aortic valve implantation: a\u00a0systematic review and meta-analysis. Eur Heart J Qual Care Clin Outcomes. 2017;3:123\u201332.","journal-title":"Eur Heart J Qual Care Clin Outcomes"},{"key":"2138_CR33","first-page":"216","volume":"3","author":"A Islam","year":"2014","unstructured":"Islam\u00a0A, Muir-Hunter\u00a0SW, Speechley\u00a0M, Montero-Odasso\u00a0M. Facilitating frailty identification: comparison of two methods among community-dwelling order adults. J\u00a0Frailty Aging. 2014;3:216\u201321.","journal-title":"J Frailty Aging"}],"container-title":["Wiener klinische Wochenschrift"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00508-022-02138-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00508-022-02138-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00508-022-02138-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,12,13]],"date-time":"2023-12-13T03:16:11Z","timestamp":1702437371000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00508-022-02138-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,1,12]]},"references-count":33,"journal-issue":{"issue":"23-24","published-print":{"date-parts":[[2023,12]]}},"alternative-id":["2138"],"URL":"https:\/\/doi.org\/10.1007\/s00508-022-02138-4","relation":{},"ISSN":["0043-5325","1613-7671"],"issn-type":[{"value":"0043-5325","type":"print"},{"value":"1613-7671","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,1,12]]},"assertion":[{"value":"29 August 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 November 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 January 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"R.\u00a0Uzel, R.\u00a0Rezar, R.R.\u00a0Bruno, S.\u00a0Wernly, C.\u00a0Jung, G.\u00a0Delle Karth, C.\u00a0Datz, F.\u00a0Hoppichler and B.\u00a0Wernly declare that they have no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This study protocol was reviewed and approved by the ethics committee of Salzburg, approval number 1170\/2020.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical standards"}}]}}